Multi-scale modeling for the transmission of influenza and the evaluation of interventions toward it

Mathematical modeling of influenza epidemic is important for analyzing the main cause of the epidemic and finding effective interventions towards it. The epidemic is a dynamic process. In this process, daily infections are caused by people's contacts, and the frequency of contacts can be mainly influenced by their cognition to the disease. The cognition is in turn influenced by daily illness attack rate, climate, and other environment factors. Few existing methods considered the dynamic process in their models. Therefore, their prediction results can hardly be explained by the mechanisms of epidemic spreading. In this paper, we developed a heterogeneous graph modeling approach (HGM) to describe the dynamic process of influenza virus transmission by taking advantage of our unique clinical data. We built social network of studied region and embedded an Agent-Based Model (ABM) in the HGM to describe the dynamic change of an epidemic. Our simulations have a good agreement with clinical data. Parameter sensitivity analysis showed that temperature influences the dynamic of epidemic significantly and system behavior analysis showed social network degree is a critical factor determining the size of an epidemic. Finally, multiple scenarios for vaccination and school closure strategies were simulated and their performance was analyzed.

[1]  R. Betts,et al.  Intranasally administered interferon as prophylaxis against experimentally induced influenza A virus infection in humans. , 1987, The Journal of infectious diseases.

[2]  J. Mestecky Saliva as a Manifestation of the Common Mucosal Immune System a , 1993, Annals of the New York Academy of Sciences.

[3]  F. Hayden,et al.  Oral LY217896 for prevention of experimental influenza A virus infection and illness in humans , 1994, Antimicrobial Agents and Chemotherapy.

[4]  R. Betts,et al.  Effect of simultaneous administration of cold-adapted and wild-type influenza A viruses on experimental wild-type influenza infection in humans , 1994, Journal of clinical microbiology.

[5]  F. Hayden,et al.  Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. , 1996, JAMA.

[6]  Franco Bagnoli,et al.  Cellular Automata , 2002, Lecture Notes in Computer Science.

[7]  F. Hayden,et al.  Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. , 1998, The Journal of clinical investigation.

[8]  F. Hayden,et al.  Respiratory nitric oxide levels in experimental human influenza. , 1998, Chest.

[9]  W G Alvord,et al.  Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. , 1999, The Journal of infectious diseases.

[10]  A. Monto Interrupting the transmission of respiratory tract infections: theory and practice. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  N. Cox,et al.  Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. , 2000, JAMA.

[12]  G. Der,et al.  Social Class, Sex, and Age Differences in Mucosal Immunity in a Large Community Sample , 2000, Brain, Behavior, and Immunity.

[13]  Dexiang Chen,et al.  Serum and Mucosal Immune Responses to an Inactivated Influenza Virus Vaccine Induced by Epidermal Powder Immunization , 2001, Journal of Virology.

[14]  R. Eccles,et al.  An Explanation for the Seasonality of Acute Upper Respiratory Tract Viral Infections , 2002, Acta oto-laryngologica.

[15]  Aravind Srinivasan,et al.  Modelling disease outbreaks in realistic urban social networks , 2004, Nature.

[16]  Cécile Viboud,et al.  Risk factors of influenza transmission in households. , 2004, The British journal of general practice : the journal of the Royal College of General Practitioners.

[17]  T. Geisel,et al.  Forecast and control of epidemics in a globalized world. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[18]  M. Newman,et al.  Network theory and SARS: predicting outbreak diversity , 2004, Journal of Theoretical Biology.

[19]  M. Hosoya,et al.  VIRAL SHEDDING IN CHILDREN WITH INFLUENZA VIRUS INFECTIONS TREATED WITH NEURAMINIDASE INHIBITORS , 2005, The Pediatric infectious disease journal.

[20]  A. Nizam,et al.  Containing Pandemic Influenza at the Source , 2005, Science.

[21]  Efficacy and Tolerability of the Oral Neuraminidase Inhibitor Peramivir in Experimental Human Influenza: Randomized, Controlled Trials for Prophylaxis and Treatment , 2005, Antiviral therapy.

[22]  D. Cummings,et al.  Strategies for containing an emerging influenza pandemic in Southeast Asia , 2005, Nature.

[23]  Pietro Liò,et al.  The Influence of Risk Perception in Epidemics: A Cellular Agent Model , 2006, ACRI.

[24]  F. Carrat,et al.  A 'small-world-like' model for comparing interventions aimed at preventing and controlling influenza pandemics , 2006, BMC medicine.

[25]  Heikki Haario,et al.  DRAM: Efficient adaptive MCMC , 2006, Stat. Comput..

[26]  D. Cummings,et al.  Strategies for mitigating an influenza pandemic , 2006, Nature.

[27]  John Steel,et al.  Influenza Virus Transmission Is Dependent on Relative Humidity and Temperature , 2007, PLoS pathogens.

[28]  Pietro Liò,et al.  Risk perception in epidemic modeling. , 2007, Physical review. E, Statistical, nonlinear, and soft matter physics.

[29]  L. Finelli,et al.  Household Responses to School Closure Resulting from Outbreak of Influenza B, North Carolina , 2008, Emerging infectious diseases.

[30]  A. Flahault,et al.  Estimating the impact of school closure on influenza transmission from Sentinel data , 2008, Nature.

[31]  N. Ferguson,et al.  Time lines of infection and disease in human influenza: a review of volunteer challenge studies. , 2008, American journal of epidemiology.

[32]  Alessandro Vespignani,et al.  influenza A(H1N1): a Monte Carlo likelihood analysis based on , 2009 .

[33]  Alessandro Vespignani,et al.  Multiscale mobility networks and the spatial spreading of infectious diseases , 2009, Proceedings of the National Academy of Sciences.

[34]  Laxminarayana Ganapathi,et al.  Synthesized Population Databases: A US Geospatial Database for Agent-Based Models. , 2009, Methods report.

[35]  Gail E. Potter,et al.  The Transmissibility and Control of Pandemic Influenza A (H1N1) Virus , 2009, Science.

[36]  J. Sung,et al.  Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza , 2009, The Journal of infectious diseases.

[37]  E. Lyons,et al.  Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings , 2009, Science.

[38]  N. Ferguson,et al.  Closure of schools during an influenza pandemic , 2009, The Lancet Infectious Diseases.

[39]  Shawn T. Brown,et al.  A computer simulation of vaccine prioritization, allocation, and rationing during the 2009 H1N1 influenza pandemic. , 2010, Vaccine.

[40]  J. Unger,et al.  Cognitive Behavioral Theories Used to Explain Injection Risk Behavior Among Injection Drug Users: A Review and Suggestions for the Integration of Cognitive and Environmental Models , 2010, Health education & behavior : the official publication of the Society for Public Health Education.

[41]  D. Earn,et al.  Effect of influenza vaccination of children on infection rates in Hutterite communities: a randomized trial. , 2010, JAMA.

[42]  Kuender D Yang,et al.  Correlation of Pandemic (H1N1) 2009 Viral Load with Disease Severity and Prolonged Viral Shedding in Children , 2010, Emerging infectious diseases.

[43]  V. Jansen,et al.  Modelling the influence of human behaviour on the spread of infectious diseases: a review , 2010, Journal of The Royal Society Interface.

[44]  Elizabeth A. Casman,et al.  Incorporating individual health-protective decisions into disease transmission models: a mathematical framework , 2012, Journal of The Royal Society Interface.

[45]  Alessandro Vespignani,et al.  Modeling human mobility responses to the large-scale spreading of infectious diseases , 2011, Scientific reports.

[46]  F. Baldanti,et al.  Viral shedding in children infected by pandemic A/H1N1/2009 influenza virus , 2011, Virology Journal.

[47]  Stefano Merler,et al.  Determinants of the Spatiotemporal Dynamics of the 2009 H1N1 Pandemic in Europe: Implications for Real-Time Modelling , 2011, PLoS Comput. Biol..

[48]  Pietro Liò,et al.  Community Structure in Social Networks: Applications for Epidemiological Modelling , 2011, PloS one.

[49]  Alessandro Vespignani,et al.  Real-time numerical forecast of global epidemic spreading: case study of 2009 A/H1N1pdm , 2012, BMC Medicine.

[50]  A. Monto,et al.  Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  Seiya Imoto,et al.  Cost-effective length and timing of school closure during an influenza pandemic depend on the severity , 2013, Theoretical Biology and Medical Modelling.

[52]  T. R. Peters,et al.  Evaluation of the limit of detection of the BD Veritor™ system flu A+B test and two rapid influenza detection tests for influenza virus. , 2013, Diagnostic microbiology and infectious disease.

[53]  Shawn T. Brown,et al.  FRED (A Framework for Reconstructing Epidemic Dynamics): an open-source software system for modeling infectious diseases and control strategies using census-based populations , 2013, BMC Public Health.

[54]  T. R. Peters,et al.  Influenza testing, diagnosis, and treatment in the emergency department in 2009-2010 and 2010-2011. , 2013, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[55]  Peter Grove,et al.  School closures during the 2009 influenza pandemic: national and local experiences , 2014, BMC Infectious Diseases.